Gene · 10
Papers3,552
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,721 to 1,740 of 3,552
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The effects of socioeconomic status, clinical factors, and genetic ancestry on pulmonary tuberculosis disease in northeastern Mexico. | PLoS One | 2014 | 24728409 | PubTator, text mining | PubMed |
| Genetic selection of volunteers and concomitant dose adjustment leads to comparable hydralazine/valproate exposure. | J Clin Pharm Ther | 2014 | 24702251 | PubTator, text mining | PubMed |
| Genomic and pharmacogenomic biomarkers of Parkinson's disease. | Curr Drug Metab | 2014 | 24694231 | PubTator, text mining | PubMed |
| Toxicokinetics of novel psychoactive substances: characterization of N-acetyltransferase (NAT) isoenzymes involved in the phase II metabolism of 2C designer drugs. | Toxicol Lett | 2014 | 24674864 | PubTator, text mining | PubMed |
| Maternal smoking, xenobiotic metabolizing enzyme gene variants, and gastroschisis risk. | Am J Med Genet A | 2014 | 24668907 | PubTator, text mining | PubMed |
| Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity. | Tuberculosis (Edinb) | 2014 | 24637014 | PubTator, text mining | PubMed |
| Effects of Seijo-bofu-to, a traditional Japanese herbal medicine containing furanocoumarin derivatives, on the drug-metabolizing enzyme activities in healthy male volunteers. | Basic Clin Pharmacol Toxicol | 2014 | 24612940 | PubTator, text mining | PubMed |
| The association between CYP2E1 polymorphisms and hepatotoxicity due to anti-tuberculosis drugs: a meta-analysis. | Infect Genet Evol | 2014 | 24607341 | PubTator, text mining | PubMed |
| Distribution of genetic polymorphisms of genes encoding drug metabolizing enzymes & drug transporters - a review with Indian perspective. | Indian J Med Res | 2014 | 24604039 | PubTator, text mining | PubMed |
| Understanding pharmacokinetics to improve tuberculosis treatment outcome. | Expert Opin Drug Metab Toxicol | 2014 | 24597717 | PubTator, text mining | PubMed |
| LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk. | Br J Cancer | 2014 | 24595004 | PubTator, text mining | PubMed |
| Impact of food intake on the pharmacokinetics of first-line antituberculosis drugs in Taiwanese tuberculosis patients. | J Formos Med Assoc | 2014 | 24594059 | PubTator, text mining | PubMed |
| Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury. | J Chin Med Assoc | 2014 | 24593909 | PubTator, text mining | PubMed |
| Prognostic relevance of urinary bladder cancer susceptibility loci. | PLoS One | 2014 | 24586564 | PubTator, text mining | PubMed |
| N-acetyltransferase 2 polymorphisms and risk of esophageal cancer in a Chinese population. | PLoS One | 2014 | 24586291 | PubTator, text mining | PubMed |
| Genome-wide association study of metabolic traits reveals novel gene-metabolite-disease links. | PLoS Genet | 2014 | 24586186 | PubTator, text mining | PubMed |
| Cholangiocarcinoma. | Lancet | 2014 | 24581682 | PubTator, text mining | PubMed |
| Levosimendan in critical illness: a literature review. | J Clin Med Res | 2014 | 24578748 | PubTator, text mining | PubMed |
| Application of microRNA and mRNA expression profiling on prognostic biomarker discovery for hepatocellular carcinoma. | BMC Genomics | 2014 | 24564407 | PubTator, text mining | PubMed |
The African Organisation for Research and Training in Cancer and its conferences: a historical perspective and highlights of the Ninth International Conference, Durban, South Africa, 21-24 November 2013. | Ecancermedicalscience | 2014 | 24550997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10/papers?page=87